EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease

Roberto A Galeana-Ascencio, Liliana Mendieta, Daniel I Limon, Dino Gnecco, Joel L Terán iD, María L Orea iD, Alan Carrasco-Carballo iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Roberto A Galeana-Ascencio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Elucidación y Síntesis en Química Orgánica, ICUAP, BUAP, Puebla 72570, Mexico. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CONACYT, ICUAP, BUAP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The β-secretase-1 enzyme (BACE-1) performs a key role in the production of beta-Amyloid protein (Aβ), which is associated with the development of Alzheimer’s disease (AD). The inhibition of BACE-1 has been an important pharmacological strategy in the treatment of this neurodegenerative disease. This study aims to identify new potential candidates for the treatment of Alzheimer’s with the help of in silico studies, such as molecular docking and ADME prediction, from a broad list of candidates provided by the DrugBank database. From this analysis, 1145 drugs capable of interacting with the enzyme with a higher coupling energy than Verubecestat were obtained, subsequently only 83 presented higher coupling energy than EJ7. Applying the oral route of administration as inclusion criteria, only 41 candidates met this requirement; however, 6 of them are associated with diagnostic tests and not treatment, so 33 candidates were obtained. Finally, five candidates were identified as possible BACE-1 inhibitors drugs: Fluphenazine, Naratriptan, Bazedoxifene, Frovatriptan, and Raloxifene. These candidates exhibit pharmacophore-specific features, including the indole or thioindole group, and interactions with key amino acids in BACE-1. Overall, this study provides insights into the potential use of in silico methods for drug repurposing and identification of new candidates for the treatment of Alzheimer’s disease, especially those targeting BACE-1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeurodegenerative DiseasesHumansAmyloid Precursor Protein SecretasesPharmaceutical PreparationsMolecular Docking SimulationAspartic Acid EndopeptidasesAmyloid beta-Peptides

Stichwörter der Autor:innen

ADMEAlzheimer’s diseasein silico drug repositionmolecular dockingβ-secretase 1

Substanzen

Amyloid Precursor Protein SecretasesPharmaceutical PreparationsAspartic Acid EndopeptidasesAmyloid beta-Peptides

Autor:innen und Institutionen

  • Laboratorio de Elucidación y Síntesis en Química Orgánica, ICUAP, BUAP, Puebla 72570, Mexico.
  • Laboratorio de Neuroquímica, FCQ, BUAP, Puebla 72570, Mexico.
  • Laboratorio de Neurofarmacología, FCQ, BUAP, Puebla 72570, Mexico.
  • Centro de Química, ICUAP, BUAP, Puebla 72570, Mexico.

ORCID-Profile: Joel L Terán, María L Orea, Alan Carrasco-Carballo

Förderung

  • CONACYT
  • ICUAP, BUAP

Zitieren

APA

Galeana-Ascencio, R. A., Mendieta, L., Limon, D. I., Gnecco, D., Terán, J. L., Orea, M. L., & Carrasco-Carballo, A. (2023). β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098164

Vancouver

Galeana-Ascencio RA, Mendieta L, Limon DI, Gnecco D, Terán JL, Orea ML, et al. β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098164

BibTeX
@article{GaleanaAscencio2023,
  author = {Galeana-Ascencio, Roberto A and Mendieta, Liliana and Limon, Daniel I and Gnecco, Dino and Terán, Joel L and Orea, María L and Carrasco-Carballo, Alan},
  title = {β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098164}
}
Kostenlos starten →